GlycoMimetics
GLYC
#10327
Rank
ยฃ7.6 M
Marketcap
ยฃ0.12
Share price
-5.42%
Change (1 day)
-49.95%
Change (1 year)

Revenue for GlycoMimetics (GLYC)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of ยฃ0 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GlycoMimetics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 ยฃ0 M-87.34%
2022 ยฃ0.06 M-92.78%
2021 ยฃ0.85 M-88.48%
2020 ยฃ7.45 M
2019 N/A
2018 N/A
2017 N/A-100%
2016 ยฃ0.01 M-99.89%
2015 ยฃ13.54 M40.32%
2014 ยฃ9.65 M298.75%
2013 ยฃ2.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
bluebird bio
BLUE
ยฃ77.97 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ35.65 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
ยฃ69.12 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA